FDA approves Zynyz as first-line treatment for advanced anal cancer
The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first first-line treatment for advanced anal cancer.
May 21, 2025
0
0